What's new

Human medicines European public assessment report (EPAR): Zinforo, ceftaroline fosamil, Date of authorisation: 22/08/2012, Revision: 28, Status: Authorised

Human medicines European public assessment report (EPAR): Zinforo, ceftaroline fosamil, Date of authorisation: 22/08/2012, Revision: 28, Status: Authorised

Feb 14, 2025 - 16:58
 0
Human medicines European public assessment report (EPAR): Zinforo, ceftaroline fosamil, Date of authorisation: 22/08/2012, Revision: 28, Status: Authorised
Human medicines European public assessment report (EPAR): Zinforo, ceftaroline fosamil, Date of authorisation: 22/08/2012, Revision: 28, Status: Authorised
Read More

Tags:

Previous Article

Allogene’s phase 1 lymphoma data show CAR-T could ‘leapfrog’ competition: analysts

Next Article

Human medicines European public assessment report (EPAR): Karvea, irbesartan, Da...

Related Posts

Human medicines European public assessment report (EPAR): Osenvelt, denosumab, Date of authorisation: 14/02/2025, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 3, 2025  0

Human medicines European public assessment report (EPAR): Imjudo, tremelimumab, Date of authorisation: 20/02/2023, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 18, 2025  0

Human medicines European public assessment report (EPAR): Veoza, fezolinetant, Date of authorisation: 07/12/2023, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 21, 2025  0